European Case Law Identifier: | ECLI:EP:BA:2018:T135415.20180301 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 01 March 2018 | ||||||||
Case number: | T 1354/15 | ||||||||
Application number: | 10184660.8 | ||||||||
IPC class: | A61K 31/713 C12N 15/113 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | D | ||||||||
Download and more information: |
|
||||||||
Title of application: | RNA sequence-specific mediators of RNA interference | ||||||||
Applicant name: | The Whitehead Institute for Biomedical Research Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Massachusetts Institute of Technology University of Massachusetts |
||||||||
Opponent name: | Silence Therapeutics AG | ||||||||
Board: | 3.3.08 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Admission of new evidence - (no) Disclaimer - added matter - (no) Sufficiency of disclosure - (yes) Novelty - (yes) Inventive step - (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t151354eu1.html
Date retrieved: 17 May 2021